OLD REPUBLIC ANNOUNCES SHARE REPURCHASE AUTHORIZATION
Get Alerts ORI Hot Sheet
Join SI Premium – FREE
Today's share repurchase authorization is in addition to the recently completed authorization, whereby 19.4 million shares of outstanding common stock were purchased at an average price per share of
Old Republic may purchase shares on a discretionary basis from time to time through open market purchases, private negotiated transactions or other means. The timing and amount of any transactions will be conducted subject to the discretion of Old Republic based upon valuation, market conditions and other considerations. Old Republic may also from time to time repurchase shares pursuant to written, pre-arranged Rule 10b5-1 plans, which will be established and conducted in accordance with applicable regulations. The repurchase program is intended to comply with Rule 10b-18 and has no expiration date, does not require the purchase of any minimum number of shares and may be suspended, modified, or discontinued at any time without prior notice.
In reaching its decision to authorize the share repurchase program, the Board of Directors evaluated such factors as the current and foreseeable liquidity and capital needs of the parent holding company and its insurance company subsidiaries.
Since
About Old Republic
For Old Republic's latest news releases and other corporate documents: Please visit us at www.oldrepublic.com | ||
Alternatively, please write or call: Investor Relations Old Republic International Corporation (312) 346-8100 | ||
At Old Republic: | At Financial Relations Board: |
Analysts/Investors: |
View original content:https://www.prnewswire.com/news-releases/old-republic-announces-share-repurchase-authorization-301822969.html
SOURCE Old Republic International Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Technological Breakthrough丨Niutech's Titanium-Iron Tailings Reduction and Enrichment Technology and Equipment Boost Global Strategic Mineral Resource Recovery
- Old Republic (ORI) Misses Q2 EPS by 2c
- Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Dividend, Stock BuybackSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share